Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1300313
European Journal of Endocrinology, Vol 130, Issue 3, 313-319
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deloof, S
Right arrow Articles by Chatelain, A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Deloof, S
Right arrow Articles by Chatelain, A

Effects of rat corticotrophin-releasing factor, arginine vasopressin and oxytocin on the secretions of adrenocorticotrophic hormone and corticosterone in the fetal rat in late gestation: in vivo and in vitro studies

S Deloof, V Montel and A Chatelain

Deloof S, Montel V, Chatelain A. Effects of rat corticotrophin-releasing factor, arginine vasopressin and oxytocin on the secretions of adrenocorticotrophic hormone and corticosterone in the fetal rat in late gestation: in vivo and in vitro studies. Eur J Endocrinol 1994;130:313–19. ISSN 0804–4643

The effects of rat corticotrophin-releasing factor (rCRF), arginine vasopressin (AVP) and oxytocin (OT) were investigated in vivo in 21 -day-old rat fetuses injected through the umbilical vein and in vitro on perifused anterior pituitary glands from 21-day-old rat fetuses. In vivo, rCRF (1.25 pmol • 50 µl–1 • fetus–1), AVP (5 pmol • 50 µl–1 •fetus–1) alone and rCRF in association with AVP or oxytocin (12.5 pmol • 50 µl–1 • fetus–1) increased plasma adrenocorticotrophic hormone (ACTH) and corticosterone levels only 30 min after the start of injection. During the first 10 min of the sampling period, the injection of these peptides alone or in combination and the injection of saline decreased the plasma ACTH concentration, which was lower than that of uninjected fetuses, but had no effect on the plasma corticosterone concentration. In vitro, the release of ACTH by perifused anterior pituitary glands was increased strongly by rCRF (4 pmol/0.5 ml) but only slightly by AVP (92 pmol/0.5 ml) and oxytocin (198 pmol/0.5 ml). Arginine vasopressin and oxytoxin potentiated the release of ACTH stimulated by rCRF in vitro but not in vivo. Our results suggest that rCRF is the major peptide that controls ACTH secretion in the fetal rat at term. In conclusion, the rise of the ACTH level observed only 30 min after injection of rCRF or AVP suggests the existence of a factor able to inhibit the ACTH response after injection of these peptides. This factor might be elicited by the blood volume expansion.

A Chatelain, Laboratoire de Neuroendocrinologie du Développement, Université des Sciences et Technologies de Lille, Bâtiment SN4, 59655 Villeneuve d'Ascq cédex, France




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Lesage, B. Blondeau, M. Grino, B. Bréant, and J. P. Dupouy
Maternal Undernutrition during Late Gestation Induces Fetal Overexposure to Glucocorticoids and Intrauterine Growth Retardation, and Disturbs the Hypothalamo-Pituitary Adrenal Axis in the Newborn Rat
Endocrinology, May 1, 2001; 142(5): 1692 - 1702.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.